DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS Share Price

Certificat

DE000ME7WVA4

Market Closed - Börse Stuttgart 17:56:25 28/05/2024 BST
405.3 EUR -1.20% Intraday chart for DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS
Current month+9.45%
1 month+9.10%
Date Price Change
28/05/24 405.3 -1.20%
27/05/24 410.2 +0.22%
24/05/24 409.4 +0.10%
23/05/24 409 +0.47%
22/05/24 407 +0.74%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 05:56 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying VERTEX PHARMACEUTICALS INCORPORATED
Issuer Morgan Stanley
WKN ME7WVA
ISINDE000ME7WVA4
Date issued 30/01/2024
Cap 450 $
Last trading day 21/06/2024
Maturity 21/06/2024 (24 Days)
Parity 1 : 1
Emission price 383.2
Emission volume N/A
Payment day 28/06/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- $
Break even 0.000000 €
Highest since issue 410.2
Lowest since issue 363.9
Distance Cap -3.12 $
Distance Cap %-0.70%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
446.9 USD
Average target price
462.8 USD
Spread / Average Target
+3.57%
Consensus